NASDAQ:AERI - Aerie Pharmaceuticals SEC Filings & 10K Form

$29.05
-0.48 (-1.63 %)
(As of 06/26/2019 11:00 AM ET)
Today's Range
$28.93
Now: $29.05
$30.02
50-Day Range
$30.34
MA: $36.83
$43.35
52-Week Range
$29.36
Now: $29.05
$74.75
Volume10,194 shs
Average Volume589,123 shs
Market Capitalization$1.33 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.86

SEC Filings

Aerie Pharmaceuticals (NASDAQ:AERI) SEC Filings

DateFilerForm TypeView
06/17/2019
3:37 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G
View Filing
06/13/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2019
5:34 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/24/2019
9:11 AM
Aerie Pharmaceuticals (Issuer)
GOLDBERG MURRAY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:16 PM
Aerie Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:14 PM
Aerie Pharmaceuticals (Issuer)
MCGRAW BENJAMIN F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:11 PM
Aerie Pharmaceuticals (Issuer)
GRYSKA DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:04 PM
Aerie Pharmaceuticals (Issuer)
du Toit Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:03 PM
Aerie Pharmaceuticals (Issuer)
Croarkin Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
5:01 PM
Aerie Pharmaceuticals (Issuer)
Cagle Gerald D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
3:24 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/17/2019
4:19 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2019
4:17 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2019
4:16 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2019
5:32 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/03/2019
6:43 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2019
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/25/2019
5:42 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/15/2019
3:12 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/15/2019
3:11 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/15/2019
3:08 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/10/2019
3:10 PM
Aerie Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/10/2019
3:03 PM
Aerie Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/08/2019
5:32 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/21/2019
5:35 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
5:38 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
5:35 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/26/2019
5:26 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
5:25 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
5:24 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
5:22 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/25/2019
3:04 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/20/2019
3:32 PM
Aerie Pharmaceuticals (Issuer)
LaRocca John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
10:30 AM
Aerie Pharmaceuticals (Subject)
HARTFORD MUTUAL FUNDS INC/CT (Filed by)
Form SC 13G
View Filing
02/13/2019
12:38 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aerie Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2019
12:00 PM
Aerie Pharmaceuticals (Subject)
Foresite Capital Fund II, L.P. (Filed by)
Form SC 13G/A
View Filing
02/12/2019
3:15 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
View Filing
02/12/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/11/2019
4:28 PM
Aerie Pharmaceuticals (Issuer)
LaRocca John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
4:27 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
4:26 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
4:25 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
4:23 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
7:34 AM
Aerie Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/04/2019
3:02 PM
Aerie Pharmaceuticals (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
View Filing
02/01/2019
7:09 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/17/2019
5:48 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
5:04 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2019
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/02/2019
3:03 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/04/2018
3:02 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
10:47 AM
Aerie Pharmaceuticals (Filer)
Form CT ORDER
View Filing
11/19/2018
3:54 PM
Aerie Pharmaceuticals (Issuer)
Cagle Gerald D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/13/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
3:29 PM
Aerie Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
11/06/2018
3:05 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/02/2018
3:02 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/23/2018
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
5:38 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/01/2018
4:31 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:11 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/19/2018
3:02 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/18/2018
3:03 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/14/2018
3:04 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/12/2018
4:14 PM
Aerie Pharmaceuticals (Issuer)
GRYSKA DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/12/2018
4:12 PM
Aerie Pharmaceuticals (Issuer)
GRYSKA DAVID W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/12/2018
3:20 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/06/2018
4:03 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/29/2018
3:02 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/22/2018
4:06 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/22/2018
4:02 PM
Aerie Pharmaceuticals (Filer)
Form 424B7
View Filing
08/15/2018
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/09/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/02/2018
3:05 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/01/2018
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/24/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/23/2018
2:54 PM
Aerie Pharmaceuticals (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/23/2018
2:53 PM
Aerie Pharmaceuticals (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
07/23/2018
2:51 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
View Filing
07/23/2018
6:39 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/23/2018
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/11/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/05/2018
3:03 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/26/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/21/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/13/2018
3:33 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
7:07 PM
Aerie Pharmaceuticals (Issuer)
MCGRAW BENJAMIN F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
7:06 PM
Aerie Pharmaceuticals (Issuer)
GOLDBERG MURRAY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
7:04 PM
Aerie Pharmaceuticals (Issuer)
du Toit Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
7:00 PM
Aerie Pharmaceuticals (Issuer)
Croarkin Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
6:58 PM
Aerie Pharmaceuticals (Issuer)
Cagle Gerald D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
6:56 PM
Aerie Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
6:48 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
6:44 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:05 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/05/2018
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2018
4:54 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 6/26/2019 by MarketBeat.com Staff

Featured Article: Dividend Aristocrat Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel